Skip to main content

Advertisement

Log in

Orchidopexy for congenital cryptorchidism in childhood and adolescence and testicular cancer in adults: an updated systematic review and meta-analysis of observational studies

  • REVIEW
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Congenital cryptorchidism is a well-established risk factor of testicular malignancies. However, there is still remarkable variability in the measures of associations between of these two clinical entities. The current meta-analysis investigates the up-to-date risk of testicular cancer in adults with a history of surgically corrected congenital cryptorchidism until adolescence. The meta-analysis was conducted with strict criteria for the identification of the congenital cryptorchidism cases that underwent surgery before adulthood. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A search of the PubMed and the Scopus databases was conducted, using a defined strategy, from inception to February 2023. Two independent authors screened the literature and extracted the data, using inclusion and exclusion criteria. Of the 2176 articles identified, 93 articles were fully retrieved, and 6 articles met all the inclusion criteria. The Newcastle–Ottawa scale was applied for the studies’ quality assessment. The random-effects model in RevMan 5.4 program was used for the meta-analysis. Three case–control studies and three cohort studies were selected. They included 371,681 patients and 1786 incidents of testicular cancer. The pooled odds ratio (OR) was 3.99 (95% confidence intervals (CI): 2.80–5.71). The heterogeneity was moderate and estimated at 51% with the I-squared statistic. A forest plot and a funnel plot were produced to evaluate the ORs and the probable publication bias, respectively. The mean Newcastle–Ottawa score was 8/9 for all the included reports.

  Conclusion: This systematic review and meta-analysis verifies, with an updated estimate, the increased risk of testicular cancer in adults with an orchidopexy history. New evidence on the maldescent laterality supports that the cancer risk remains increased and for the contralateral, unaffected testicle, although to a lesser extent. The orchidopexy in the first year of life prevents the testicular damage and decreases the overall cancer risk.

What is Known:

Congenital cryptorchidism is the commonest genitourinary abnormality and a risk factor for testicular cancer.

The most recent meta-analysis reporting this association was in 2013.

What is New:

After reviewing literature until February 2023, the association of congenital cryptorchidism with testicular cancer risk in adulthood was verified: odds ratio=3.99 [2.80–5.71], 95% CI.

The meta-analysis highlights the protective role of early orchidopexy and the controversial data about maldescent and testicular cancer laterality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

Data available upon request.

Abbreviations

CI:

Confidence intervals

hCG:

Human chorionic gonadotropin

HIV:

Human immunodeficiency virus

ICD:

International Classification of Diseases

MeSH:

Medical Subject Headings

NOS:

Newcastle Ottawa Scale

OR:

Odds ratio

RR:

Risk ratio

SD:

Standard deviation

References

  1. Kim SO, Hwang EC, Hwang IS, Oh KJ, Jung SI, Kang TW, Kwon D, Park K, Bang-Ryu S (2011) Testicular catch-up growth: the impact of orchiopexy age. Urology 78(4):886–889. https://doi.org/10.1016/j.urology.2011.04.057

    Article  PubMed  Google Scholar 

  2. Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R (2013) A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child 98(1):20–26. https://doi.org/10.1136/archdischild-2012-302051

    Article  PubMed  Google Scholar 

  3. Kolon TF, Herndon CD, Baker LA, Baskin LS, Baxter CG, Cheng EY, Diaz M, Lee PA, Seashore CJ, Tasian GE, Barthold JS (2014) American Urological Association. (2014) Evaluation and treatment of cryptorchidism: AUA guideline. J Urol 192(2):337–45. https://doi.org/10.1016/j.juro.2014.05.005

  4. Hutson JM, Thorup J (2015) Evaluation and management of the infant with cryptorchidism. Curr Opin Pediatr 27(4):520–524. https://doi.org/10.1097/MOP.0000000000000237

    Article  CAS  Google Scholar 

  5. Loebenstein M, Thorup J, Cortes D, Clasen-Linde E, Hutson JM, Li R (2020) Cryptorchidism, gonocyte development, and the risks of germ cell malignancy and infertility: a systematic review. J Pediatr Surg 55(7):1201–1210. https://doi.org/10.1016/j.jpedsurg.2019.06.023

    Article  PubMed  Google Scholar 

  6. Feyles F, Peiretti V, Mussa A, Manenti M, Canavese F, Cortese MG, Lala R (2014) (2014) Improved sperm count and motility in young men surgically treated for cryptorchidism in the first year of life. Eur J Pediatr Surg 24(5):376–380. https://doi.org/10.1055/s-0033-1349715

    Article  PubMed  Google Scholar 

  7. Hensel KO, Caspers T, Jenke AC, Schuler E, Wirth S (2015) Operative management of cryptorchidism: guidelines and reality--a 10-year observational analysis of 3587 cases. BMC Pediatr 15:116. https://doi.org/10.1186/s12887-015-0429-1

  8. Hack WW, Meijer RW, Van Der Voort-Doedens LM, Bos SD, De Kok ME (2003) (2003) Previous testicular position in boys referred for an undescended testis: further explanation of the late orchidopexy enigma? BJU Int 92(3):293–296. https://doi.org/10.1046/j.1464-410x.2003.04317.x

    Article  CAS  PubMed  Google Scholar 

  9. Wei Y, Wu SD, Wang YC, Lin T, He DW, Li XL, Liu JH, Liu X, Hua Y, Lu P, Zhang DY, Wen S, Wei GH (2016) A 22-year retrospective study: educational update and new referral pattern of age at orchidopexy. BJUInt 118(6):987–993. https://doi.org/10.1111/bju.13588

    Article  Google Scholar 

  10. Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14. https://doi.org/10.1007/s00345-004-0398-8

    Article  PubMed  Google Scholar 

  11. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):e1000100. https://doi.org/10.1371/journal.pmed.1000100

  12. Higgins JPT, Green S (editors) (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Cochrane Collab

  13. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605. https://doi.org/10.1007/s10654-010-9491-z

    Article  PubMed  Google Scholar 

  14. Review Manager (RevMan) [Computer program] (2020) Version 5.4. Cochrane Collab

  15. Schneuer FJ, Milne E, Jamieson SE, Pereira G, Hansen M, Barker A, Holland AJA, Bower C, Nassar N (2018) Association between male genital anomalies and adult male reproductive disorders: a population-based data linkage study spanning more than 40 years. Lancet Child Adolesc Health 2(10):736–743. https://doi.org/10.1016/S2352-4642(18)30254-2

    Article  PubMed  Google Scholar 

  16. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O (2007) Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356(18):1835–1841. https://doi.org/10.1056/NEJMoa067588

    Article  CAS  PubMed  Google Scholar 

  17. Prener A, Engholm G, Jensen OM (1996) Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 7(1):14–9. https://doi.org/10.1097/00001648-199601000-00004

  18. Forman D, Pike MC, Davey G, Dawson S, Baker K, Chilvers CE et al (1994) Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise BMJ 308:1393. https://doi.org/10.1136/bmj.308.6941.1393

    Article  Google Scholar 

  19. Strader CH, Weiss NS, Daling JR, Karagas MR, McKnight B (1988) Cryptorchism, orchiopexy, and the risk of testicular cancer. Am J Epidemiol 127(5):1013–1018. https://doi.org/10.1093/oxfordjournals.aje.a114877

    Article  CAS  PubMed  Google Scholar 

  20. Swerdlow AJ, Huttly SR, Smith PG (1987) Testicular cancer and antecedent diseases. Br J Cancer 55(1):97–103. https://doi.org/10.1038/bjc.1987.20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA (2010) A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer–experiences of the son. Int J Epidemiol 39(6):1605–1618. https://doi.org/10.1093/ije/dyq120

    Article  PubMed  PubMed Central  Google Scholar 

  22. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ (2007) Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 178(4 Pt 1):1440–6; discussion 1446. https://doi.org/10.1016/j.juro.2007.05.166

  23. Baird DC, Meyers GJ, Hu JS (2018) Testicular cancer: diagnosis and treatment. Am Fam Physician 97(4):261–268

    PubMed  Google Scholar 

  24. Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common develop- mental disorder with environmental aspects. Hum Reprod 16:972. https://doi.org/10.1093/humrep/16.5.972

    Article  CAS  PubMed  Google Scholar 

  25. Akre O, Pettersson A, Richiardi L (2009) Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta analysis. Int J Cancer 124(3):687–689. https://doi.org/10.1002/ijc.23936

    Article  CAS  PubMed  Google Scholar 

  26. Wood HM, Elder JS (2009) Cryptorchidism and testicular cancer: separating fact from fiction. J Urol 181(2):452–461. https://doi.org/10.1016/j.juro.2008.10.074

    Article  PubMed  Google Scholar 

  27. Banks K, Tuazon E, Berhane K, Koh CJ, De Filippo RE, Chang A, Kim SS, Daneshmand S, Davis-Dao C, Lewinger JP, Bernstein L, Cortessis VK (2013) Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics. Front Endocrinol (Lausanne) 18(3):182. https://doi.org/10.3389/fendo.2012.00182

    Article  Google Scholar 

  28. Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H (2007) Nordic consensus on treatment of undescended testes. Acta Paediatr 96(5):638–643. https://doi.org/10.1111/j.1651-2227.2006.00159.x

    Article  PubMed  Google Scholar 

  29. Radmayr C, Dogan HS, Hoebeke P, Kocvara R, Nijman R, Silay S, Stein R, Undre S, Tekgul S (2016) Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines. J Pediatr Urol 12(6):335–343. https://doi.org/10.1016/j.jpurol.2016.07.014

    Article  PubMed  Google Scholar 

  30. Allin BSR, Dumann E, Fawkner-Corbett D, Kwok C, Skerritt C (2018) Paediatric Surgery Trainees Research Network. Systematic review and meta-analysis comparing outcomes following orchidopexy for cryptorchidism before or after 1 year of age. BJS Open 2(1):1–12. https://doi.org/10.1002/bjs5.36

  31. Dawson DV, Pihlstrom BL, Blanchette DR (2016) Understanding and evaluating meta-analysis. J Am Dent Assoc 147(4):264–270. https://doi.org/10.1016/j.adaj.2015.10.023

    Article  PubMed  Google Scholar 

  32. Khan S, Memon B, Memon MA (2019) Meta-analysis: a critical appraisal of the methodology, benefits and drawbacks. Br J Hosp Med (Lond) 80(11):636–641. https://doi.org/10.12968/hmed.2019.80.11.636

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Study concept and design: Maria Florou, Evangelia Ntzani, Christos Kaselas. Acquisition of data: Maria Florou, Christos Kaselas. Analysis and interpretation of data: Maria Florou, Evangelia Ntzani, Ekaterini Siomou, Triantafyllia Koletsa. Drafting of the manuscript: Maria Florou. Statistical analysis: Maria Florou, Konstantinos Tsilidis, Evangelia Ntzani. Prepared figures and tables: Ekaterini Siomou, Ioannis Spyridakis, Antonia Syrnioti. All authors reviewed the manuscript. Supervision: Christos Kaselas, Evangelia Ntzani.

Corresponding author

Correspondence to Maria Florou.

Ethics declarations

Ethics approval

This is a systematic review and meta-analysis of observational studies. No ethics approval is required.

Conflict of interest

The authors declare no competing interests.

Additional information

Communicated by Gregorio Milani.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Florou, M., Tsilidis, K.K., Siomou, E. et al. Orchidopexy for congenital cryptorchidism in childhood and adolescence and testicular cancer in adults: an updated systematic review and meta-analysis of observational studies. Eur J Pediatr 182, 2499–2507 (2023). https://doi.org/10.1007/s00431-023-04947-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-023-04947-9

Keywords

Navigation